683 related articles for article (PubMed ID: 18367739)
21. Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.
Lemonne N; Charlot K; Waltz X; Ballas SK; Lamarre Y; Lee K; Hierso R; Connes C; Etienne-Julan M; Romana M; Connes P
Haematologica; 2015 Oct; 100(10):e383-6. PubMed ID: 26137960
[No Abstract] [Full Text] [Related]
22. Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy.
O'branski EE; Ware RE; Prose NS; Kinney TR
J Am Acad Dermatol; 2001 May; 44(5):859-61. PubMed ID: 11312437
[TBL] [Abstract][Full Text] [Related]
23. Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease.
Gille AS; Pondarré C; Dalle JH; Bernaudin F; Chalas C; Fahd M; Jean C; Lezeau H; Riou L; Drouineaud V; Paye-Jaouen A; Kamdem A; Neven B; Arnaud C; Azarnoush S; Yakouben K; Sarnacki S; de Montalembert M; Comperat EM; Lenaour G; Sibony M; Dhédin N; Vaiman D; Wolf JP; Patrat C; Fouchet P; Poirot C; Barraud-Lange V
Blood; 2021 Feb; 137(6):856-859. PubMed ID: 33259585
[No Abstract] [Full Text] [Related]
24. [Effect of hydroxyurea on adhesion proteins in sickle cell anemia].
Odièvre MH; Lapouméroulie C; Elion J
Arch Pediatr; 2009 Feb; 16(2):95-8. PubMed ID: 19167870
[No Abstract] [Full Text] [Related]
25. Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.
Olujohungbe A; Cinkotai KI; Yardumian A
BMJ; 1998 Jun; 316(7146):1689. PubMed ID: 9614013
[No Abstract] [Full Text] [Related]
26. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
[TBL] [Abstract][Full Text] [Related]
27. Hydroxyurea use in patients with sickle cell disease in a Medicaid population.
Ritho J; Liu H; Hartzema AG; Lottenberg R
Am J Hematol; 2011 Oct; 86(10):888-90. PubMed ID: 21922530
[No Abstract] [Full Text] [Related]
28. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.
Brawley OW; Cornelius LJ; Edwards LR; Gamble VN; Green BL; Inturrisi C; James AH; Laraque D; Mendez M; Montoya CJ; Pollock BH; Robinson L; Scholnik AP; Schori M
Ann Intern Med; 2008 Jun; 148(12):932-8. PubMed ID: 18458271
[No Abstract] [Full Text] [Related]
29. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
Al-Jam'a AH; Al-Dabbous IA
Saudi Med J; 2002 Mar; 23(3):277-81. PubMed ID: 11938415
[TBL] [Abstract][Full Text] [Related]
30. Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatment.
Makis AC; Hatzimichael EC; Kolios G; Bourantas KL
Haematologica; 2004 Mar; 89(3):360-1. PubMed ID: 15020278
[TBL] [Abstract][Full Text] [Related]
31. Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia.
Taylor JG; Darbari DS; Maric I; McIver Z; Arthur DC
Ann Intern Med; 2011 Nov; 155(10):722-4. PubMed ID: 22084346
[No Abstract] [Full Text] [Related]
32. Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi.
Mvalo T; Topazian H; Kamthunzi P; Chen J; Kambalame I; Mafunga P; Mumba N; Chiume-Chiphaliwali M; Paseli K; Key N; Gopal S; Hoffman I; Ataga K; Westmoreland K
Blood Adv; 2018 Nov; 2(Suppl 1):30-32. PubMed ID: 30504195
[No Abstract] [Full Text] [Related]
33. Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease.
Grigg A
Intern Med J; 2007 Mar; 37(3):190-2. PubMed ID: 17316339
[TBL] [Abstract][Full Text] [Related]
34. Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia.
Jayabose S; Tugal O; Sandoval C; Patel P; Puder D; Lin T; Visintainer P
J Pediatr; 1996 Oct; 129(4):559-65. PubMed ID: 8859263
[TBL] [Abstract][Full Text] [Related]
35. Hydroxyurea in the treatment of sickle-cell anemia.
Howard LW; Kennedy LD
Ann Pharmacother; 1997 Nov; 31(11):1393-6. PubMed ID: 9391697
[TBL] [Abstract][Full Text] [Related]
36. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
Wang WC; Wynn LW; Rogers ZR; Scott JP; Lane PA; Ware RE
J Pediatr; 2001 Dec; 139(6):790-6. PubMed ID: 11743503
[TBL] [Abstract][Full Text] [Related]
37. Management of sickle cell disease.
Steinberg MH
N Engl J Med; 1999 Apr; 340(13):1021-30. PubMed ID: 10099145
[No Abstract] [Full Text] [Related]
38. Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review.
DeBaun MR
Expert Rev Hematol; 2014 Dec; 7(6):767-73. PubMed ID: 25242414
[TBL] [Abstract][Full Text] [Related]
39. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
Okam MM; Ebert BL
Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
[TBL] [Abstract][Full Text] [Related]
40. Hydroxyurea for children with sickle cell disease: are we starting too late?
Mueller BU
Pediatr Blood Cancer; 2011 Jan; 56(1):3-4. PubMed ID: 21058289
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
